16.565  0.075 (0.45%)		06-18 10:06
Open: 16.49 High: 16.565 Volume: 173		Pre. Close: 16.49 Low: 16.3 Market Cap: 31(M)

Short term
Mid term
Targets	6-month :	22.07	1-year :	25.78
Resists	First :	18.89	Second :	22.07
Pivot price	16.18
Supports	First :	15.87	Second :	14.01
MAs	MA(5) :	16.07	MA(20) :	16.62
	MA(100) :	14.47	MA(250) :	36.16
MACD	MACD :	0.4	Signal :	0.5
%K %D	K(14,3) :	40.3	D(3) :	31.4
RSI	RSI(14): 56.4
52-week	High :	86	Low :	5.26

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ EUDA ] has closed below upper band by 40.0%. Bollinger Bands are 71% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	16.59 - 16.68	16.68 - 16.74
Low:	16.29 - 16.38	16.38 - 16.45
Close:	16.35 - 16.5	16.5 - 16.61

EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited.

Thu, 18 Jun 2026
EUDA Health Holdings Ltd (EUDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Thu, 18 Jun 2026
EUDA Health Holdings Ltd (EUDA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Thu, 18 Jun 2026
EUDA Health Holdings Ltd (EUDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Thu, 11 Jun 2026
EUDA Health (NASDAQ: EUDA) suspends ATM offering, files termination notice - Stock Titan

Wed, 10 Jun 2026
EUDA (EUDA) suspends and terminates $10M at-the-market share offering with Chardan - Stock Titan

Mon, 01 Jun 2026
EUDA Health Holdings Limited Expands Helixé Product Line with Launch of Regenixé iPSC-derived Skin Stem Cell Secretome Mask - Quiver Quantitative

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Healthcare Information Services
Shares Out	3 (M)
Shares Float	1 (M)
Held by Insiders	49.4 (%)
Held by Institutions	0 (%)
Shares Short	8 (K)
Shares Short P.Month	87 (K)

EPS	-1.49
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-2.25
Profit Margin	-40.7 %
Operating Margin	-34.8 %
Return on Assets (ttm)	-89.4 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	78.9 %
Gross Profit (p.s.)	1
Sales Per Share	2.28
EBITDA (p.s.)	-0.75
Qtrly Earnings Growth	0 %
Operating Cash Flow	-2 (M)
Levered Free Cash Flow	-1 (M)

PE Ratio	-11.15
PEG Ratio	0
Price to Book value	-7.33
Price to Sales	7.22
Price to Cash Flow	-20.3

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.